We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.18
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.02 (11.111%)
Open: 0.19
High: 0.00
Low: 0.00
Prev. Close: 0.19
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Apr 2022 15:44

RNS Number : 6981H
Nuformix PLC
07 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYW79Y38

Issuer Name

NUFORMIX PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

CPI Enterprises Limited

City of registered office (if applicable)

Redcar

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

04-Apr-2022

6. Date on which Issuer notified

07-Apr-2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.750000

0.000000

3.750000

26600000

Position of previous notification (if applicable)

4.320000

0.000000

4.320000

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYW79Y38

26600000

 

3.750000

 

Sub Total 8.A

26600000

3.750000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

07-Apr-2022

13. Place Of Completion

Wilton, Redcar, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLSSUFLWEESEDL
Date   Source Headline
1st Feb 20227:00 amRNSAdviser Appointments
31st Jan 20222:09 pmRNSDirector/PDMR Shareholding
31st Jan 202211:05 amRNSResult of General Meeting
17th Jan 20229:56 amRNSPosting of Circular and Notice of General Meeting
10th Jan 20224:23 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSHolding(s) in Company
14th Dec 20212:05 pmRNSSecond Price Monitoring Extn
14th Dec 20212:00 pmRNSPrice Monitoring Extension
14th Dec 20217:01 amRNSSubscription to raise £1.65 million
14th Dec 20217:00 amRNSHalf year Report
25th Nov 20217:00 amRNSPositive pre-clinical data on NXP002
17th Nov 20219:34 amRNSHolding(s) in Company
12th Nov 20217:00 amRNSNXP004 patent application filing
9th Nov 20217:00 amRNSDirectorate Change
4th Oct 20212:01 pmRNSPrice Monitoring Extension
16th Sep 20212:14 pmRNSDirector/PDMR Shareholding - Replacement
16th Sep 202112:47 pmRNSDirector/PDMR Shareholding
13th Sep 20217:00 amRNSLicensing agreement with Oxilio for NXP001
24th Aug 202111:57 amRNSResult of AGM
23rd Jul 20211:35 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20217:00 amRNSLetter to shareholders re: Dr Anne Brindley
21st Jul 20214:41 pmRNSSecond Price Monitoring Extn
21st Jul 20214:36 pmRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSDirectorate Change
15th Jul 20217:00 amRNSFinal results for the year ended 31 March 2021
10th Jun 20219:25 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSNotice of Allowance of Patent in US
1st Jun 20217:00 amRNSProject update - Progress on NXP002 and NXP004
24th May 20217:00 amRNSDirectorate Changes
12th May 202111:35 amRNSHolding(s) in Company
11th May 20211:51 pmRNSHolding(s) in Company
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20213:30 pmRNSCorrection: Holding(s) in Company
8th Apr 202111:54 amRNSHolding(s) in Company
6th Apr 202110:38 amRNSHolding(s) in Company
30th Mar 20215:14 pmRNSHolding(s) in Company
29th Mar 202111:27 amRNSResult of General Meeting and Total Voting Rights
22nd Mar 20217:00 amRNSNXP001 (Oncology) - Exercise of Option by Oxilio
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
19th Mar 202111:05 amRNSSecond Price Monitoring Extn
19th Mar 202111:00 amRNSPrice Monitoring Extension
19th Mar 20219:05 amRNSSecond Price Monitoring Extn
19th Mar 20219:00 amRNSPrice Monitoring Extension
11th Mar 20217:00 amRNSInitiation of research by Allenby Capital
10th Mar 202111:05 amRNSSecond Price Monitoring Extn
10th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20219:05 amRNSSecond Price Monitoring Extn
10th Mar 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.